Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Felbor

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Journal of the Neurological Sciences|July 18, 2016
Propranolol stops progressive multiple cerebral cavernoma in an adult patientMatthias Reinhard, Florian Schuchardt, Stephan Meckel, et al.
American Journal of Medical Genetics. Part A|December 18, 2018
Identification of pathogenic YY1AP1 splice variants in siblings with Grange syndrome by whole exome sequencingMatthias Rath, Stefanie Spiegler, Tim M Strom, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|October 27, 2025
Modifiable cancer risk factors and their association with hereditary cancer awareness and knowledge, and attitudes toward genetic cancer testing: a cross-sectional survey among German primary care patientsDiana Guertler, Ann-Kristin Reinhard, Sabina Ulbricht, et al.
Journal of the Neurological Sciences|July 10, 2016
Authors' response to the letter by Dr. Eisa-BeygiMatthias Reinhard, Florian Schuchardt, Stephan Meckel, et al.
Journal of the Neurological Sciences|April 22, 2019
Exome sequencing identifies a recurrent SOX2 deletion in a patient with gait ataxia and dystonia lacking major ocular malformationsRobin A Pilz, G Christoph Korenke, Rainer Steeb, et al.
Neurogenetics|July 28, 2007
CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformationsKatrin Voss, Sonja Stahl, Elisa Schleider, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 8, 2005
Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explantsSabine Gaetzner, Martine M L Deckers, Sonja Stahl, et al.
Neurogenetics|December 4, 2017
First large genomic inversion in familial cerebral cavernous malformation identified by whole genome sequencingStefanie Spiegler, Matthias Rath, Sabine Hoffjan, et al.
Human Mutation|April 17, 2009
Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 proteinKatrin Voss, Sonja Stahl, Benjamin M Hogan, et al.
Neurosurgical Review|June 24, 2021
Long-term outcome and quality of life after CNS cavernoma resection: eloquent vs. non-eloquent areasLoay Shoubash, Jörg Baldauf, Marc Matthes, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Journal of the Neurological Sciences|July 18, 2016
Propranolol stops progressive multiple cerebral cavernoma in an adult patientMatthias Reinhard, Florian Schuchardt, Stephan Meckel, et al.
American Journal of Medical Genetics. Part A|December 18, 2018
Identification of pathogenic YY1AP1 splice variants in siblings with Grange syndrome by whole exome sequencingMatthias Rath, Stefanie Spiegler, Tim M Strom, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|October 27, 2025
Modifiable cancer risk factors and their association with hereditary cancer awareness and knowledge, and attitudes toward genetic cancer testing: a cross-sectional survey among German primary care patientsDiana Guertler, Ann-Kristin Reinhard, Sabina Ulbricht, et al.
Journal of the Neurological Sciences|July 10, 2016
Authors' response to the letter by Dr. Eisa-BeygiMatthias Reinhard, Florian Schuchardt, Stephan Meckel, et al.
Journal of the Neurological Sciences|April 22, 2019
Exome sequencing identifies a recurrent SOX2 deletion in a patient with gait ataxia and dystonia lacking major ocular malformationsRobin A Pilz, G Christoph Korenke, Rainer Steeb, et al.
Neurogenetics|July 28, 2007
CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformationsKatrin Voss, Sonja Stahl, Elisa Schleider, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 8, 2005
Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explantsSabine Gaetzner, Martine M L Deckers, Sonja Stahl, et al.
Neurogenetics|December 4, 2017
First large genomic inversion in familial cerebral cavernous malformation identified by whole genome sequencingStefanie Spiegler, Matthias Rath, Sabine Hoffjan, et al.
Human Mutation|April 17, 2009
Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 proteinKatrin Voss, Sonja Stahl, Benjamin M Hogan, et al.
Neurosurgical Review|June 24, 2021
Long-term outcome and quality of life after CNS cavernoma resection: eloquent vs. non-eloquent areasLoay Shoubash, Jörg Baldauf, Marc Matthes, et al.
Pageof 8